Tai chi

Studies of tai chi in people

156 studies gave tai chi to people and measured what changed

What changedDesignPeopleSource

down: Decreases WOMAC pain-3.22 points (95% CI -3.96 to -2.48); P < 0.001

up: Improves physical function

Randomized trial12 weeks116 peopleolder adultsOlder adults; knee osteoarthritisJournal of pain research, Nov 6, 2026

up: Improves attention control

Trial58 peoplePatients with cerebral small vessel disease and mild cognitive impairmentFrontiers in cell and developmental biology, Oct 30, 2026

up: Improves fatigue

up: Improves sleep qualitymedian: 6.0, IQR: 5.0–7.0

up: Improves 6-min walk distancemean: 490.2, SD: 50.7

Randomized trial12 weeks64 people31 (48.4%) were male18-60 yearsKidney transplant recipients aged 18–60 years who were at least 1 month post-transplantationNursing research and practice, Oct 13, 2026

up: Improves cognitive functionβ = 4.95, 95% CI [3.98, 5.92]

up: Increases cerebral blood flowβ = 15.29, 95% CI [12.58, 17.99]

up: Increases nitric oxideβ = 10.41, 95% CI [5.02, 15.79]

Randomized trial12 weeks40 peoplepostmenopausal womenaged 50–75 yearsPostmenopausal women with MCIFrontiers in aging neuroscience, Sep 25, 2026

down: Decreases timed Up and Go time−2.52 s (95% CI, −3.43 to −1.61)

down: Decreases knee pain−3.22 points (95% CI, −5.29 to −1.16)

Randomized trial12 weeks96 peopleaged 65–85 yearsCommunity-dwelling adults with sarcopenic knee osteoarthritisOsteoarthritis and cartilage open, Sep 23, 2026

up: Increases skeletal muscle mass

down: Decreases percentage of fat mass

up: Improves sit-stand test

Trialsix months123 people60 to 74 yearsOlder adults aged 60 to 74 years without severe cognitive impairment or risk of sarcopeniaSports (Basel, Switzerland), Sep 1, 2026

down: Decreases 12-HETE

down: Decreases 1-arachidonoylglycerol

up: Increases 18-HEPE

Trialfour sessions on non-consecutive days within a 10 d window16 peoplewomen58.9 ± 5.2 years oldSelf-reported postmenopausal womenFrontiers in medicine, Aug 31, 2026

up: Improves clinical function

Randomized trial12 weeks50 peopleolder adultsOlder adults; Parkinson diseaseArchives of physical medicine and rehabilitation, Aug 28, 2026

down: Decreases body fat percentage

down: Decreases fasting blood glucose

down: Decreases IFN-γ

Trial12 weeks19 peoplemiddle-aged and elderlyMidlife adults; Older adults; in people with pre-diabetes, after 12 weeksCurrent Drug Therapy, Jul 16, 2026

down: Decreases painSMD = −0.85 [95% CI = −1.15 to −0.56]

Review of trialsranged between 1 week and 240 weeks221,279 people pooledmost reviews (n = 135) included both female and male participants (females only, n = 22)ranged between 20 and 79 yearsAdults aged 18 years and older (healthy and clinical)Pain reports, Jul 6, 2026

down: Decreases stressfrom 15.96 ± 5.71 to 12.46 ± 3.47 (t = 4.274; p < 0.000)

Trial21 days28 peopleolder adultsOlder adultsNurse and Health Jurnal Keperawatan, Jul 6, 2026

down: Decreases WOMAC pain score

Review of trials2,095 people pooledmiddle-aged and older adults (mean age 58 to 79 years)Midlife adults; Older adults; Patient cohortsFrontiers in medicine, Jul 2, 2026

down: Decreases loneliness

up: Improves social self-efficacy

Randomized trialsix months140 people52% women and 48% menrange 65 to 85 years, mean 70.03 ± 8.46 yearsOlder adults living aloneBMC psychology, Jul 2, 2026

up: Improves static balance+94.0%, Cohen's d=1.85, p<0.001

up: Improves dynamic balance-17.8% TUG time, p<0.001

up: Improves Berg Balance Scale+7.0%, p<0.001

Trial12 weeks40 people65-75 yearsOlder adultsInterdisciplinary Academic and Research Journal, Jul 2, 2026

up: Improves postural stability

up: Improves gait quality

Randomized trial12 weeks68 peopleBothmean 71.1 yearsOlder adultsJournal of neuroengineering and rehabilitation, Jun 24, 2026

up: Increases physical activityfrom 14.2 MET h/wk at baseline to 28.7 MET h/wk post-intervention (p < 0.001)

up: Improves social participationp = 0.014

Trial8 weeks60 people60-77 yearsOlder adults; adults aging with mobility disabilitiesHealthcare (Basel, Switzerland), Jun 18, 2026

down: Decreases plantar tactile sensation thresholdp = 0.007, OR = 0.111, 95%CI: 0.023-0.544

down: Decreases ankle proprioception thresholdp < 0.002, η 2 p = 0.355

Randomized trial8 weeks38 peopleBoth71.5 ± 5.3 yearsOlder adults; peripheral neuropathyFrontiers in sports and active living, Jun 17, 2026

up: Improves balance

Randomized trial12 weeks60 people60–80 yearsOlder adults; Patient cohortsJournal of Health Wellness and Community Research, Jun 2, 2026

up: Improves muscle strengthp = 0.003

Trial10 peopleOlder adultsJurnal Keperawatan Profesional (KEPO), May 31, 2026

up: Improves Mini-Mental State ExaminationΔ = 3.29, 0.81 to 5.77, pHolm = 0.0492

up: Improves immediate story recallΔ = 9.84, 3.22 to 16.46, pHolm = 0.0234

Randomized trial24 weeks76 peopleBoth86.8 ± 4.1 yearsThe oldest old; assisted living facility residents aged ≥80Journal of affective disorders, May 5, 2026

up: Improves motor symptoms

up: Improves quality of life

Randomized trial14 weeksParkinson's disease (Hoehn and Yahr stages 2-3)Behavioural brain research, May 2, 2026

down: Decreases low-density lipoprotein cholesterol

up: Improves short Physical Performance Battery

up: Improves WHOQOL quality of life

Randomized trial12 weeks113 peoplemiddle-aged and older adults, mean 62.3 yearsMidlife adults; Older adultsJMIR aging, Apr 23, 2026

down: Decreases COP-RMSml

up: Improves Timed Up-and-Go

Randomized trial8 weeks40 peopleolder adultsOlder adults; older adults with diabetic peripheral neuropathyBrain research, Apr 17, 2026

down: Decreases Pittsburgh Sleep Quality IndexP < 0.001

up: Increases N3 sleep stage proportion+23.1%

up: Increases delta wave powerP < 0.01

Randomized trial12 weeks67 people65-75 yearsOlder adults; mild sleep disturbanceFrontiers in physiology, Apr 15, 2026

down: Decreases hip-ankle angular range during stair ascent

Randomized trial12-week69 peopleolder adultsOlder adults; postintervention, within Tai Chi groupJournal of applied biomechanics, Mar 31, 2026

up: Improves cognitive function

up: Improves gait

up: Increases hip range of motion

Trialthree months40 peopleBothaged 60 years and olderParticipants aged 60 years and older with mild cognitive impairmentFrontiers in physiology, Mar 23, 2026

down: Decreases 4-meter walk test time

down: Decreases sit-to-stand test time

up: Increases handgrip strength

Trialsix months81 peopleolder womenaged 60 to 74 yearsCommunity-dwelling older Mexican women aged 60 to 74Healthcare (Basel, Switzerland), Mar 5, 2026

down: Decreases knee pain

up: Improves joint range of motion

up: Improves muscle strength

Trial20–30 minutesolder adultsOlder adults; osteoarthritisJurnal Kesehatan Amanah, Feb 24, 2026

down: Decreases fasting blood glucose

down: Decreases body weight

up: Increases gut microbiota diversity

Trial6 months36 peopleIn patients with type 2 diabetes mellitusFrontiers in public health, Feb 6, 2026

up: Improves Cumberland Ankle Instability Tool+10.32 vs +2.84 points, P<.01

down: Decreases pain intensityP<.05

up: Improves balanceP<.05

Randomized trial12 weeks50 peopleBoth65.44±8.75yOlder adults; functional ankle instabilityArchives of rehabilitation research and clinical translation, Feb 4, 2026

up: Improves positive emotional changesBTJQ > GBTJQ > GTJQ > TJQ

Randomized trialacuteMenelderlyOlder adultsFrontiers in psychology, Feb 4, 2026

down: Decreases systolic blood pressure

down: Decreases IL-6

up: Increases IL-10

Randomized trial24 weeks31 peoplePatients with hypertension and coronary heart diseaseBMC complementary medicine and therapies, Feb 3, 2026

down: Decreases depression

up: Improves balance ability

Randomized trial12 and 24 weeks46 peoplemean age 61 yearsOlder adults; advanced cancerEuropean journal of oncology nursing : the official journal of European Oncology Nursing Society, Jan 30, 2026

up: Improves global cognitionΔ = +0.46, p = 0.0045

up: Increases skeletal muscle mass

down: Decreases IL-6

Randomized trial12 weeks22 peopleBothmean 62.3 yearsOlder adults; 12-form Chen-style Tai Chi arm, 12 weeks, versus controlExperimental gerontology, Jan 22, 2026

up: Improves cognitive function

down: Decreases homocysteine

Randomized trial24-week26 peopleIn patients with CSVDGeroScience, Jan 21, 2026

up: Improves working memory0-back accuracy +0.118, 95% CI: 0.048-0.188

up: Improves global cognitionMoCA +3.07, 95% CI: 0.89-5.25

Randomized trial26 weeks93 peopleolder adultsOlder adults; mild cognitive impairmentFrontiers in public health, Jan 6, 2026

down: Decreases painVAS SUCRA 0.97

up: Improves physical healthSF-36 PCS SUCRA 0.89

Review of trials1,457 people pooledmiddle-aged and older adultsMidlife adults; Older adults; SUCRA ranking in Bayesian network meta-analysisFrontiers in public health, Jan 6, 2026

up: Increases physical activity

up: Improves social connectedness

down: Decreases loneliness

Trial8 weeks60 peopleolder adultsOlder adults; aging with mobility disabilitiesGSA 2025 abstract, Dec 31, 2025

up: Increases deep stabilizing muscle activation1.327 ± 0.085 vs 1.468 ± 0.246

down: Decreases lumbar rotation around the z-axis−2.096 ± 1.025 vs −1.957 ± 0.682

Trial12 people6 males, 6 femalesHealthy adultsFrontiers in sports and active living, Dec 5, 2025

down: Decreases insomnia severitybetween group difference of 0.68 (−∞ to 2.00)

Randomized trialthree month programme200 people≥50 yearsMiddle aged and older adults aged ≥50 years who were ethnic Chinese and had a diagnosis of chronic insomniaBMJ (Clinical research ed.), Nov 26, 2025